Patients with idiopathic pulmonary fibrosis who were given pirfenidone or nintedanib declined more slowly, researchers in two studies reported.
via NYT > Health http://ift.tt/1nbtm8z
via All Health and Fitness http://ift.tt/1sIrWnx
No comments:
Post a Comment